Use of observed within-person variation of cardiac troponin in emergency department patients for determination of biological variation and percentage and absolute reference change values

Clinical Chemistry

Volumn 60, Issue 6, 2014, Pages 848-854

  Simpson, Aaron J ^a   Potter, Julia M ^a,b   Koerbin, Gus ^a,c   Oakman, Carmen ^a   Cullen, Louise ^d,e   Wilkes, Garry J ^f   Scanlan, Samuel L ^g   Parsonage, William ^d,e   Hickman, Peter E ^a,b  

^a ACT Pathology   (Australia)

^b Canberra Hospital   (Australia)

^c UNIVERSITY OF CANBERRA   (Australia)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^e QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^f Calvary Hospital   (Australia)

^g CANBERRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN I;

ABSOLUTE REFERENCE CHANGE VALUE; ACUTE CORONARY SYNDROME; ARTICLE; BIOASSAY; CONCENTRATION (PARAMETERS); EMERGENCY WARD; FEMALE; HIGH SENSITIVITY CARDIAC TROPONIN I ASSAY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; REFERENCE VALUE; WITHIN PERSON BIOLOGICAL VARIATION;

ACUTE CORONARY SYNDROME; BIOLOGICAL MARKERS; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; ROC CURVE; TIME FACTORS; TROPONIN I;

EID: 84901790353     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2013.219410     Document Type: Article

References (24)

1. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. Eur Heart J 2012;33:2551-67.
2. Collinson PO, Heung YM, Gaze D, Boa F, Senior R, Christenson R, Apple FS. Influence of population selection on the 99th percentile reference value for cardiac troponin assays. Clin Chem 2012;58:219-25.
3. McKie PM, Heublein DM, Scott CG, Gantzer ML, Mehta RA, Rodeheffer RJ, et al. Defining highsensitivity cardiac troponin concentrations in the community. Clin Chem 2013;59:1099-107.
4. Koerbin G, Abhayaratna WP, Potter JM, Apple FS, Jaffe AS, Ravalico TH, Hickman PE. Effect of population selection on 99th percentile values for a high sensitivity cardiac troponin I and T assays. Clin Biochem 2013;46:1636-43.
5. Cullen L, Muller C, Parsonage WA, Wildi K, Greenslade JH, Twerenbold R, et al. Validation of highsensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergencydepartment patients with possible acute coronary syndrome. J Am Coll Cardiol 2013;62:1242-9.
6. Goodacre S. The health care burden of acute chest pain. Heart 2005;91:229-30.
7. Chew DP, Aroney CN, Aylward PE, Kelly AM, White HD, Tideman PA, et al. Addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand Guidelines for the management of acute coronary syndromes (ACS) 2006. Heart Lung Circ 2011;20:487-502.
8. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-STElevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 2007;14;50:e1-e157.
9. Reichlin T, Irfan A, Twerenbold R, Reiter M, Hochholzer W, Burkhalter H et al. Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation 2011;124:136-45.
10. Koerbin G, Tate J, Potter JM, Cavanaugh J, Glasgow N, Hickman PE. Characterization of a highly sensitive TnI assay and its application to a cardiohealthy population. Clin Chem Lab Med 2012;50:871-8.
11. Abbott ARCHITECT STAT High Sensitive Troponin-I [Package Insert]. Abbott Laboratories, Chicago, IL; 2012.
12. Antman EM, Cohen M, Bernink PJLM, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina/non-ST elevation MI. A method for prognostication and therapeutic decision making. JAMA 2000;284:835-42. (Pubitemid 30643610)
13. Koerbin G, Potter JM, Abhayaratna WP, Telford RD, Badrick T, Apple FS, et al. Longitudinal studies of cardiac troponin I in a large cohort of healthy children. Clin Chem 2012;58:1665-72.
14. Fokkema MR, Herrmann Z, Muskiet FAJ, Moecks J. Reference change values for brain natriuretic peptides revisited. Clin Chem 2006;52:1602-3. (Pubitemid 44148325)
15. Badrick T, Wilson S, Dimeski G, Hickman PE. Objective determination of appropriate reporting intervals. Ann Clin Biochem 2004;41:385-90. (Pubitemid 39279924)
16. Jones GRD. Effect of the reporting-interval size on critical difference estimation: beyond "2.77." Clin Chem 2006;52:880-5. (Pubitemid 43673267)
17. Wu AHB. Biological and analytical variation of clinical biomarker testing: implications for biomarker-guided therapy. Curr Heart Failure Rep 2013;10:434-40.
18. Horowitz GL, Altaie A, Boyd JC, Ceriotto F, Garg U, Horn P, et al. Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline - third edition. Wayne (PA): CLSI; 2008. CLSI document no. EP28-A3c.
19. Nordenskjold AM, Ahlstrom H, Eggers KM, Frobert O, Jaffe AS, Venge P, Lindahl B. Short-and long-term individual variation in cardiac troponin in patients with stable coronary artery disease. Clin Chem 2013;59:401-9.
20. Apple FS, Collinson PO. Analytical characteristics of high sensitivity cardiac troponin asays. Clin Chem 2012;58:54-61.
21. Goldberg J, Iriate B, Prostko J, Frias E, Ravalico T, Hebbar S. Short and long-term biological variation of troponin-I determined using the ARCHITECT STAT high sensitive troponin-I assay. Clin Chem 2011;57(10 Suppl):A97.
22. Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H et al. Guidelines: ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent STsegment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011;32:2999-3054.
23. Mueller M, Biener M, Vafaie M, Doerr S, Keller T, Blankenberg S, et al. Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome. Clin Chem 2012;58:209-18.
24. Than M, Cullen L, Aldous S, Parsonage WA, Reid CM, Greenslade J et al. 2-Hour accelerated diagnostic protocol to assess patients with chest pain symptoms using contemporary troponins as the only biomarker. The ADAPT Trial. J Am Coll Cardiol 2013;59:2091-8.